IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.
By M. Abuzzahab, A. Schneider, A. Goddard, F. Grigorescu, C. Lautier, E. Keller, W. Kiess, J. Klammt, J. Kratzsch, D. Osgood and 5 more. New England Journal of Medicine, 2003
623 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/ab3b0a16b3f6c74e4ced994e2ac62e32f964eb6f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Fässler
- S. Wickström
- K. Legate
- Roger Smith
- V. Murphy
- V. Clifton
- W. Giles
Citations in the corpus
- Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. (2006, background): “sociated with poor prenatal and postnatal growth (139).”
- Genetic and cell biological analysis of integrin outside-in signaling. (2009, background): “Integrin-mediated control of insulin-like growth factor (IGF-1) receptor (IGF1R) signaling IGF-1 and IGF1R play important roles in growth and development; mutations in IGF-1 or IGF1R result in growth retardation in both mice and humans (Liu et al. 1993; Arends et al. 2002; Abuzzahab et al. 2003).”